The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

DENTSPLY International Inc

Nasdaq: XRAY
Last

(U.S.) $53.26

Today's change0.00 0.00%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

DENTSPLY International Inc

Nasdaq: XRAY
Last

(U.S.) $53.26

Today's change0.00 0.00%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

DENTSPLY International Inc down slightly

DENTSPLY International Inc closed down just (U.S.)$0.00 Friday to (U.S.)$53.26. Shares have lost 0.69% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 12.32% during the last year.

Key company metrics

  • Open(U.S.) $52.79
  • Previous close(U.S.) $53.26
  • High(U.S.) $53.55
  • Low(U.S.) $52.76
  • Bid / Ask-- / --
  • YTD % change-0.019%
  • Volume637,910
  • Average volume (10-day)884,723
  • Average volume (1-month)957,739
  • Average volume (3-month)740,677
  • 52-week range(U.S.) $43.83 to (U.S.) $57.61
  • Beta1.40
  • Trailing P/E28.49×
  • P/E 1 year forward20.55×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.29
  • Dividend yield0.54%
  • Trailing EPS(U.S.) $1.87
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.07%

Based on its net profit margin of 10.07%, DENTSPLY International Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue698656719708
Total other revenue--------
Total revenue698656719708
Gross profit400373393388
Total cost of revenue298283326320
Total operating expense612559616599
Selling / general / administrative275270283276
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)39573
Other operating expenses, total--------
Operating income8698103110
Interest income (expense), net non-operating-10-11-12-13
Gain (loss) on sale of assets--------
Other--------
Income before tax77879598
Income after tax52688376
Income tax, total25191121
Net income44648575
Total adjustments to net income--------
Net income before extra. items44648575
Minority interest0000
Equity in affiliates-8-41-1
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items44648575
Inc. avail. to common incl. extra. items44648575
Diluted net income44648575
Dilution adjustment00----
Diluted weighted average shares142142144144
Diluted EPS excluding extraordinary itemsvalue per share0.310.450.590.52
Dividends per sharevalue per share0.070.070.070.07
Diluted normalized EPSvalue per share0.500.480.620.54